← Volver al ranking

Similares a Vaccination in undifferentiated connective tissue disease (UCTD)

20 vecinos (text_768) · 103 views · ERN ReCONNET · —

★Vaccination in undifferentiated connective tissue disease (UCTD)

ERN ReCONNET

@ernreconnet

103—
1Hydroxychloroquine in connective tissue diseases: benefits and controversial aspects

ERN ReCONNET

@ernreconnet

1.8K—93
19CAR-T Therapy in Systemic Lupus Erythematosus (SLE): Explained to the Patient

ERN ReCONNET

@ernreconnet

441—88
13Quality of life in Relapsing Polychondritis (RP)

ERN ReCONNET

@ernreconnet

412—88
18Kidney involvement in Sjögren’s Disease (SjD)

ERN ReCONNET

@ernreconnet

401—88
12Why morning joint stiffness and swelling in rheumatic diseases?

ERN ReCONNET

@ernreconnet

398—88
16Pregnancy in women with primary Sjögren’s disease

ERN ReCONNET

@ernreconnet

380—88
11Autoantibodies and clinical phenotypes in Idiopathic Inflammatory Myopathies (IIMs)

ERN ReCONNET

@ernreconnet

286—88
4Treatment of systemic sclerosis-associated interstitial lung disease: where do we stand in 2025?

ERN ReCONNET

@ernreconnet

285—89
8Pulmonary Function Tests: A Practical Guide for Rheumatologists

ERN ReCONNET

@ernreconnet

253—89
10Exercise as a non-pharmacological treatment adjunct to pharmacotherapy in systemic sclerosis.

ERN ReCONNET

@ernreconnet

222—88
5The transition from benign to secondary Raynaud’s phenomenon

ERN ReCONNET

@ernreconnet

186—89
9The Path to Better Treatments: A Patient-Friendly Guide to Sjögren’s Clinical Trials

ERN ReCONNET

@ernreconnet

171—89
15Imaging in Relapsing Polychondritis (RP)

ERN ReCONNET

@ernreconnet

171—88
17Tackling heterogeneity in Sjögren’s disease: the role of stratification and clustering

ERN ReCONNET

@ernreconnet

137—88
3Osteoporosis in rare and complex connective tissue diseases

ERN ReCONNET

@ernreconnet

96—90
6Unmet Needs in Childhood-Onset Sjögren's Disease – Patient and Clinician Perspectives

ERN ReCONNET

@ernreconnet

82—89
2Pregnancy in undifferentiated connective tissue disease (UCTD)

ERN ReCONNET

@ernreconnet

72—91
14Multidisciplinary diagnosis and team treatment in Idiopathic Inflammatory Myopathies

ERN ReCONNET

@ernreconnet

64—88
20Screening and treatment of systemic sclerosis-associated PAH: where do we stand in 2024?

ERN ReCONNET

@ernreconnet

53—88
7Genetic Testing in the Era of NGS: Lessons from the Hereditary Connective Tissue Disorders

ERN ReCONNET

@ernreconnet

35—89